Healthcare ❯ Pharmaceuticals

Antibiotics

Usage Guidelines Doxycycline Resistance Mechanisms Novel Therapies Legislation Research and Development Oral Antibiotics Clinical Trials Drug Development Antimicrobial Resistance Drug Resistance Prescriptions Prescription Practices

FDA Approves Utebzi as First Oral Carbapenem for Complicated UTIs

The decision gives adults with limited or no oral options a potential substitute for hospital-based intravenous therapy.

Liverpool Researchers Report Novltex, a Synthetic Antibiotic Class Against Multidrug-Resistant Bacteria